Nevertheless, it is noteworthy that the EV-based hybrid systems discussed above were developed using EVs from various cancer cell lines that are known to bear overexpressed levels of CD47 on their surface membrane [58], which could explain how EVs equipped sNPs with immune protection properties. The gene discussed is CD47; the disease is cancer.